The use of a pH-dependent and Non pH-dependent natural hydrophobic biopolymer (Landolphia owariensis latex) as capsule coating agents in in vitro controlled release of metronidazole for possible colon targeted delivery

International Journal of Applied Research in Natural Products

Volumn 3, Issue 1, 2010, Pages 1-17

  Obitte, N C ^a   Chukwu, A ^a   Onyishi, I V ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Colon targeting; Controlled drug release; Eudragit ; L 100; Landolphia owariensis; Metronidazole

Indexed keywords

LANDOLPHIA OWARIENSIS;

EID: 80051594469     PISSN: None     EISSN: 19406223     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Anthony CD. 1995. Natural preservatives from Landolphia owariensis. Afr Dev J 2, 1:21-22.
2. Adikwu MU, Ossai AO. 1994. Evaluation of Landolphia dulcis pseudolatex as a granulating fluid for aminophylline tablets .Acta Pharma 44:157-162.
3. Akhgari A, Garekani HA, Sadeghi F, Azimaie M. 2005.Statistical optimization of indomethacin pellets coated with pH dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm 305:22-30.
4. Abraham S, Srinath MS. 2007. Development of modified pulsincap drug delivery system of metronidazole for drug targeting. Indian J Pharm Sci 69,1: 24-27.
5. Ashford M, Fell JT. 1994.Targeting drugs to the colon: delivery systems for oral administration. J Drug Target 2:241-258.
6. Arshia S, Manna PK, Paranjothy KLK, Manjula M. 2007. Entrapment of Andrographolide in cross-linked alginate pellets: I. formulation and evaluation of associated release kinetics. Pak J Pharm Sci 20,1:1-9.
7. Asghar LFA, Chandran S. 2006. Multiparticulate formulation approach to colon specific drug delivery:Current perspectives. J Pharm Pharmaceut.Sci. 9,3:327-338.
8. Blackley DC. 1966. High Polymer lattices-MacLaren and sons Ltd London.3-5.
9. Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, Jain SK. 2006. Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech 7,3:Article 74.
10. Chourasia MK, Jain SK. 2003. Pharmaceutical Approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 6 (1): 33-66.
11. Chu JS. 2003. Advances in colon specific drug delivery system employing the CODEST™. Technology/Industry overviews. The drug deliveries company report Autumn/Winter, Pharmaventures Ltd 36-40.
12. Cole ET, Scott RA, Connor AL, Wilding IR, Petereit HU, Schminke C, Beckert T, Cade D. 2002. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 231: 83-95.
13. Costa P, Lobo JMS. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123-133.
14. Davis SS. 1990.Overcoming barriers to the oral administration of peptides. Trends Pharm Sci 11:353-355.
15. Evans DF, Pye G, Bramley R, Clark A.G, Dyson TJ, Hardcastle JD. 1988.Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035-1041.
16. Emami J. 2006. In vitro - in vivo Correlation: From theory to applications. J Pharm Pharmaceut Sci 9(2):169-189.
17. Ebi GC, Ofoefule SI. 1997. Investigation into the Folkloric Antimicrobial Activities of Landolphia owariensis Phytother Res 11, 2:149-151.
18. Fassihi R, Durig T. 2003. Amino acid modulated extended release dosage form. US Patent 6,517,868 B2, February 11.
19. Gupta VK, Assmus MW, Beckert TE, Price JC. 2001. A novel PH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm 213:93-102.
20. Hixson AW, Crowell JH. 1931. Dependence of reaction velocity upon surface and agitation 1.Theoretical consideration, Ind Eng Chem 23:923-931.
21. Hinton JM, Lennard-Jonnes JE, Young AC. 1969. A new method for studying gut transit times using radioopaque markers. Gut 10:842.
22. Higuchi T. 1963. Mechanism of sustained action medication. J. Pharm Sci 1145-1148.
23. Ibekwe VC, Kendall RA, Basit AW. 2004. Drug delivery to the colon, The drug delivery companies report, spring/summer. Pharmaventures Ltd.
24. Irvine FR. 1961.The Woody Plants of Ghana, Oxford University Press, London 26-28.
25. Kinget R, Kalala W, Vervoot L, Van Den MG. 1998. Colonic drug targeting. J Drug Target 6:129-149.
26. Katikaneni PR, Upadrashta, SM, Neau SH, Mitra AK. 1995. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int J Pharm 123: 119-125.
27. Korsemeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. 1983. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 25-35.
28. Krishnaiah YSR, Seetha DA, Nageswara RL, Bhaskar RPR, Karthikeyan RS, Fassihi R, Ritschel WA. 1993. Multiple-layer, direct compression, controlled release system: in vitro and in vivo evaluation. J Pharm Sci 82: 750-754.
29. Kramar A, Turk S, Vrecer F. 2003. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films.- Int. J. Pharm. 256, 43-52.
30. Kuksal A, Ashok KT, Narendra KJ, Subheet J. 2006. Formulation and In Vitro, In Vivo Evaluation of Extendedrelease Matrix Tablet of Zidovudine: Influence of Combination of Hydrophilic and Hydrophobic Matrix Formers. AAPS PharmSciTech.7, 1,1: E1-E9.
31. Kumar P, Singh S, Mishra B. 2008. Colon targeted delivery systems of metronidazole based on osmotic technology: Development and evaluation. Chem Pharm Bull 56,9:1234-1242.
32. Leopold, CS. 1999. Coated dosage forms for colon-specific drug delivery. PSTT 2:197-204.
33. Lourdes O, Manuela I, Rosa, M., Hernández AR, Gascón JLP. 2005. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharmaceut Sci 8 (2):132-140.
34. th edn. vol.1. Limmer, D.Ed. Lippincott Williams and Wilkins, Philadelphia, U.S.A.
35. Masuda K, Ashraful SM, Parvin A, Mohiuddin AQ, Selim R.Krishn. 2004.Controlled release of naproxen sodium from Eudragit RS 100-transdermal film. Pharm J 3:1-2.
36. MacNeil ME, Rashid A, Stavens HNE. 1990. Dispensing device. World patent. WO 9009168
37. Nasra MA, EL-Massik MA, Naggar VF. 2007. Development of metronidazole colon-specific delivery systems. J Pharm Sci 2, 1:18-28.
38. Nwaogu LA, Alisi CS, Igwe CU, Ujowundu CO. 2008. Comparative study of the antimicrobial properties of the ethanolic extracts of Landolphia owariensis leaf and root. Afr. J. Biotech. 7, 4:368-372.
39. Owoyele BY, Olayele SB, Elegbe RA. 2002. Anti-inflammatory and Analgesic Activities of Leaf Extracts of Landolphia owareinsis. Afr J Biomed Res 4,3:131-133.
40. Obitte NC, Chukwu A. 2007. Physicotechnical properties of theophylline capsules prepared with Tacca involucrata starch. W J Pharm 20, 1: 23-30.
41. Pillay, V, Fassihi R. 2000. Monolithic tablet for controlled drug release. US Patent 6, 090411, July 18
42. Ravi V, Pramod K, Siddaramaiah TM. 2008. Novel colon targeted drug delivery system using natural polymers. Ind. J. Pharm. Scs. 70(1):111-113.
43. Rubinstein A. 1995. Approaches and opportunities in colon specific drug delivery. Crit Rev Ther Drug Carrier Sys 12: 101-149.
44. Ruiz A, Llacer JM, Morales E, Gallardo V. 2004. Physical characteristics of polymer complexes in suspension obtained from cellulosic latexes with ondansetron. J Mat Sci Mat Med 15: 659-664.
45. Toshikiro K., Kazutaka H. 2002. Gastrointestinal Transit and Drug Absorption. Biol. Pharm. Bull., 25,2: 149-164.
46. Schacht E, Gevaert A, El Refaie K, Koen M, Verstraete W.Krishn. 1996. Adriaensens Polymers for colon specific drug delivery. J Control. Release 39:327-328.
47. Sarasija S, Hota A. 2000. Colon specific drug delivery systems. Ind J Pharm Sci 62:1-8.
48. Satyanarayana V. 2001. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets. J Pharm Pharmaceut Sci 4(3):235-243.
49. Stamm A, Tritsch JC. Krishn. 1986. Some considerations on the liberation of drugs from inert matrices. Drug Dev Ind Pharm 12: 2337-2353.
50. Sreenivas SA, Hiremath SP, Godbole AM. 2006. Ofloxacin ocular inserts: Design, Formulation and Evaluation. I. J Pharm Therap 5:159-162.
51. th edn., Mc Graw Hill, New York, NY, 995-998,1012-1015.
52. Turner S, Federici C, Hite M, Fassihi R. 2004. Formulation Development and Human In vitro in-vivo Correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin. Drug. Dev. Ind. Pharm. 30, 8:797-807.
53. Tanwar YS, Naruka PS, Ojha GR. 2007. Development and evaluation of floating microspheres of verapamil hydrochloride. Braz J Pharm Sci, 43, 4: 529-534.
54. Van Den Mooter, G. Kinget R. 1995. Oral colon-specific drug delivery: a review. Drug Deliv. 2:81-93.
55. Wilding R, Davis SS, Pozzi F, Furlani P, Gazzaniga A. 1994. Enteric coated timed release systems for colonic targeting. Int. J. Pharm.111, 99-102.
56. Wilding IR. 2001. The enterion capsule: a novel technology for understanding the biopharmaceutical complexity of new molecular entities (NMEs). Drug Deliv Tech., 1,1: 8-11.
57. Yoshikawa Y, Hu Z, Kimura G, Murakami M, Yoshikawa H, Takada H. 1999. A dissolution test for a pressurecontrolled colon delivery capsule: rotating beads method. J Pharm Pharmacol 51:979-989.
58. Zambito Y, Giacomo D. 2003. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J Pharm Pharmaceut Sci 6,2:274-281.